Home Analyst Ratings

Analyst Ratings

Random

Analyst Activity – Raymond James Financial Reiterates Outperform on Range Resources (NYSE:RRC)

ME Staff - January 29, 2018

Analyst Activity – Boenning Scattergood Reiterates Buy on NYSE:SPG – Simon Property Group (NYSE:SPG)

Analyst Upgrades – PPL Corporation (NYSE:PPL) Stock Gets Upgraded By Jefferies Group LLC from Hold to Buy

Analyst Activity – Jefferies Group LLC Reiterates Hold on Chesapeake Energy Corporation (NYSE:CHK)

Analyst Activity – Canaccord Genuity Reiterates Buy on NASDAQ:SIEN – Sientra (NASDAQ:SIEN)

Analyst Activity – Credit Suisse Group Raises Its Price Target On...

ME Staff - April 27, 2018

Analyst Activity – Berenberg Bank Lowers Its Price Target On UBM...

ME Staff - August 2, 2017

Analyst Activity – Goldman Sachs Group, Inc. (The) Reiterates Neutral on...

ME Staff - July 25, 2017

Analyst Activity – Morgan Stanley Reiterates Buy on Allergan (NYSE:AGN)

ME Staff - January 24, 2018

Analyst Activity – Investec Reiterates Sell on Gocompare.Com Group PLC (LON:GOCO)

ME Staff - August 1, 2017

Analyst Activity – Stephens Reiterates Hold on Carolina Financial Corporation (NASDAQ:CARO)

ME Staff - July 24, 2017

Analyst Activity – FinnCap Reiterates Corporate on Best of the Best...

ME Staff - July 25, 2017

Analyst Downgrades – NASDAQ:COUP – Coupa (NASDAQ:COUP) Stock Gets Downgraded By...

ME Staff - May 18, 2018

Analyst Downgrades – NYSE:ALE – Allete (NYSE:ALE) Stock Gets Downgraded By...

ME Staff - May 7, 2018

Analyst Activity – Stifel Nicolaus Reiterates Buy on NYSE:BUD – Anheuser-Busch...

ME Staff - April 19, 2018

12 3...1,738 Page 1 of 1,738

EDITOR PICKS

Crypto Daily Roundup: June 21

June 21, 2018

Market Morning: Fox Goes to Disney Land, OPEC Meeting Tomorrow

June 21, 2018

Market Morning: Chinese US Investment Collapses, Canadian Cannabis, GE Gets DOWnsized

June 20, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.